Significance of acute-phase inflammatory reactants as an indicator of prognosis after acute myocardial infarction: Which is the most useful predictor?

Journal of Cardiology

Volumn 42, Issue 2, 2003, Pages 49-56

  Katayama, Toshiro ^a   Nakashima, Hiroshi ^a   Yonekura, Tsuyoshi ^a   Honda, Yukiharu ^a   Suzuki, Shin ^a   Yano, Katsusuke ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Heart failure; Myocardial contraction; Myocardial infarction, treatment; Prognosis; Shock

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CREATINE KINASE; INTERLEUKIN 6; SERUM AMYLOID A; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CHRONICITY; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART DEATH; HEART FAILURE; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE REPERFUSION; HEART VENTRICULOGRAPHY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; SHOCK; BLOOD; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MIDDLE AGED;

ACUTE-PHASE PROTEINS; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; SERUM AMYLOID A PROTEIN; VENTRICULAR FUNCTION, LEFT;

EID: 0141652821     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Plutzky J: Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001; 88: 10K-15K
2. Retterstol L, Eikvar L, Bohn M, Bakken A, Erikssen J, Berg K: C-reactive protein predicts death in patients with previous premature myocardial infarction: A 10 year follow-up study. Atherosclerosis 2002; 160: 433-440
3. Stefanadis C, Diamantopoulos L, Dernellis J, Economou E, Tsiamis E, Toutouzas K, Vlachopoulos C, Toutouzas P: Heat production of atherosclerotic plaques and inflammation assessed by the acute phase proteins in acute coronary syndromes. J Mol Cell Cardiol 2000; 32: 43-52
4. Ikeda U, Ito T, Shimada K: Interleukin-6 and acute coronary syndrome. Clin Cardol 2001; 24: 701-704
5. Blankenberg S, Rupprecht HJ, Bickel C, Hafner G, Meyer J: The role of inflammation and infection in acute coronary syndrome. Herz 2001; 26: 9-18 (in German with Eng abstr)
6. Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, Siostrzonek P, Huber K, Heinz G: Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med 2002; 30: 1987-1994
7. Link A, Bohm M, Nickenig G: Acute coronary syndrome: Better risk stratification by determination of inflammatory parameters? Med Klin 2002; 97: 63-69 (in German with Eng abstr)
8. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, Mitamura H, Ogawa S: Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: A possible role for left ventricular remodeling. J Am Coll Cardiol 2002; 39: 241-246
9. Sturk A, Hack CE, Aarden LA, Brouwer M, Koster RR, Sanders GT: Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: A pilot study. J Lab Clin Med 1992; 119: 574-579
10. Liuzzo G, Biasucci LM, Gallimore JR, Caligiuri G, Buffon A, Rebuzzi AG, Pepys MB, Maseri A: Enhanced inflammatory response in patients with preinfarction unstable angina. J Am Coll Cardiol 1999; 34: 1696-1703
11. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunward E: Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002; 105: 1760-1763
12. Pietila KO, Harmoinen AP, Jokiniitty J, Pasternack AI: Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 1996; 17: 1345-1349
13. Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP: C-reactive protein and myocardial infarction. J Clin Epidemiol 2002; 55: 445-451
14. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E: Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol 2000; 35: 358-362
15. Casl MT, Surina B, Glojnaric-Spasic I, Pape E, Jagarinec N, Kranjcevic S: Serum amyloid A protein in patients with acute myocardial infarction. Ann Clin Biochem 1995; 32: 196-200
16. Passni F, Morelli B, Seveso G, Lazzati L, Beria G, Del Rosso G, D'Urbano M, Cafierro F, Mariani G, De Servi S: Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes. Ital Heart J 2002; 3: 28-33
17. Kimura K, Kosuge M, Ishikawa T, Shimizu M, Endo T, Hongo Y, Tochikubo O, Umemura S: Relationship between myocardial damage and C-reactive protein levels immediately after onset of acute myocardial infarction. Jpn Circ J 2001; 65: 67-70
18. Borras Palle S, Gomez Martinez E, Romero Rodrigo A, Campos Ferrer C, Molina E, Valentin Segura V: Inflammation study in unstable angina and myocardial infarction without ST segment elevation: Value of ultra-sensitive C-reactive protein. An Med Interna 2002; 19: 283-288 (in Spanish with Eng abstr)
19. Sheehan FH, Schofer J, Mathey DG, Kellett MA, Smith H, Bolson EL, Dodge HT: Measurement of regional wall motion from biplane contrast ventricurograms: A comparison of the 30 degree right anterior oblique and 60 degree left anterior oblique projections in patients with acute myocardial infarction. Circulation 1986; 74: 796-804
20. Morishima I, Sone T, Tsuboi H, Kondo J, Mukawa H, Kamiya H, Hieda N, Okumura K: Plasma C-reavtive protein predicts left ventricular remodeling and function after a first acute anterior wall myocardial infarction treated with coronary angioplasty: Comparison with brain natriuretic peptide. Clin Cardiol 2002; 25: 112-116
21. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, Ogawa S: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997; 96: 778-784
22. Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E: Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 1993; 126: 1299-1304
23. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, Hartford M, Caidahl K: N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106: 2913-2918
24. Darbar D, Davidson NC, Gillespie N, Choy AM, Lang CC, Shyr Y, McNeill GP, Pringle TH, Struthers AD: Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 1996; 78: 284-287
25. Omland T, Arkvaag A, Bonarjee VV, Caidahl K, Lie RT, Nielsen DW, Sundsfjord JA, Dickstein K: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 93: 1963-1969
26. Walter DH, Fichtcherer S, Britten MB, Posin P, Auch-Schwelk W, Schachinger V, Zeiher AM: Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol 2001; 38: 2006-2012
27. Strandberg TE, Vanhanen H, Tikkanen MJ: Associations between change in C-reactive protein and serum lipids during statin treatment. Ann Med 2000; 32: 579-583